Nanjing, capital of East China's Jiangsu province, launched a program in 2018 to build itself into a major global innovation hub by 2025. Biomedicine is one of the tech sectors that the city aims to develop as one of its dominant industries, whose total output is targeted to contribute four-fifths of the city's GDP this year. Last year, Nanjing's GDP was 1.4 trillion yuan, up 7.8 percent year-on-year.
In all, it will focus on four advanced manufacturing sectors: electronics and information; smart equipment; biomedicine and new materials; and green, smart automobiles, as well as several emerging future-oriented industries. In addition, modern services are also under its spotlight: software and information; finance and technology; culture and health; and modern logistics and high-end commerce.
During the first quarter of the year, technology sectors have helped anchor the economy of Nanjing against the COVID-19 disruption. The output of high-tech manufacturing sectors grew by 7.9 percent year-on-year to 134.42 billion yuan, outpacing the whole industrial sector by 7.1 percentage points, the local statistics bureau said.
In the face of challenges posed by the COVID-19 epidemic, the city must stick to innovation as the major source of development and continue its endeavor in promoting innovation as Nanjing's distinctive edge, Zhang Jinghua, Party secretary of Nanjing, said in a recent meeting.
Source: China Daily
